Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-CANCER J CLIN. 2024;74(3):229–63. https://doi.org/10.3322/caac.21834.
Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J HEPATOL. 2022;77(6):1598–606. https://doi.org/10.1016/j.jhep.2022.08.021.
Article PubMed PubMed Central Google Scholar
Llovet JM, Pinyol R, Yarchoan M, Singal AG, Marron TU, Schwartz M, et al. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma. NAT REV CLIN ONCOL. 2024;21(4):294–311. https://doi.org/10.1038/s41571-024-00868-0.
Article PubMed PubMed Central Google Scholar
Wang Q, Li J, Zhang Z, Li Y, Liang Y, Chen X, et al. The effectiveness and safety of therapies for hepatocellular carcinoma with tumor thrombus in the hepatic vein, inferior Vena cave and/or right atrium: a systematic review and single-arm meta-analysis. EXPERT REV ANTICANC. 2025;25(5):561–70. https://doi.org/10.1080/14737140.2025.2489651.
Zhong B, Fan W, Guan JJ, Peng Z, Jia Z, Jin H, et al. Combination locoregional and systemic therapies in hepatocellular carcinoma. LANCET GASTROENTEROL. 2025;10(4):369–86. https://doi.org/10.1016/S2468-1253(24)00247-4.
Li J, Liang Y, Wang Q, Li Y, Chen X, Luo W, et al. Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis. FRONT IMMUNOL. 2025;15:1519999. https://doi.org/10.3389/fimmu.2024.1519999.
Article CAS PubMed PubMed Central Google Scholar
Chan Y, Zhang C, Wu J, Lu P, Xu L, Yuan H, et al. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. MOL CANCER. 2024;23(1):189. https://doi.org/10.1186/s12943-024-02101-z.
Article PubMed PubMed Central Google Scholar
Li Y, Wu S, Wu Y, Zhang W, Wang Y, Li Y, et al. Portal venous and hepatic arterial coefficients predict Post-Hepatectomy overall and Recurrence-Free survival in patients with hepatocellular carcinoma: A retrospective study. J HEPATOCELL CARCINO. 2024;11:1389–402. https://doi.org/10.2147/JHC.S462168.
Aggarwal A, Bharadwaj S, Corredor G, Pathak T, Badve S, Madabhushi A. Artificial intelligence in digital pathology - time for a reality check. NAT REV CLIN ONCOL. 2025. https://doi.org/10.1038/s41571-025-00991-6.
Ma Y, Jamdade S, Konduri L, Sailem H. AI in histopathology explorer for comprehensive analysis of the evolving AI landscape in histopathology. NPJ DIGIT MED. 2025;8(1):156. https://doi.org/10.1038/s41746-025-01524-2.
Article PubMed PubMed Central Google Scholar
Wagner VM. Is histopathology deep learning artificial intelligence the future of precision oncology?? J CLIN ONCOL. 2024;42(30):3513–6. https://doi.org/10.1200/JCO-24-01271.
Gupta R, Kurc T, Sharma A, Almeida JS, Saltz J. The emergence of pathomics. CURR PATHOBIOL REP. 2019;7(3):73–84. https://doi.org/10.1007/s40139-019-00200-x.
Ochi M, Komura D, Ishikawa S. Pathology foundation models. JMA J. 2025;8(1):121–30. https://doi.org/10.31662/jmaj.2024-0206.
Song AH, Jaume G, Williamson DFK, Lu MY, Vaidya A, Miller TR, et al. Artificial intelligence for digital and computational pathology. Nat Reviews Bioeng. 2023. https://doi.org/10.1038/s44222-023-00096-8.
Bergstrom EN, Abbasi A, Diaz-Gay M, Galland L, Ladoire S, Lippman SM, et al. Deep learning artificial intelligence predicts homologous recombination deficiency and platinum response from histologic slides. J CLIN ONCOL. 2024;42(30):3550–60. https://doi.org/10.1200/JCO.23.02641.
Article CAS PubMed Google Scholar
Bjartell A, Krzyzanowska A, Liu VYT, Tierney M, Royce TJ, Sjostrom M, et al. Validation of a digital pathology-based multimodal artificial intelligence biomarker in a prospective, real-world prostate cancer cohort treated with prostatectomy. CLIN CANCER RES. 2025. https://doi.org/10.1158/1078-0432.CCR-24-3656.
Article PubMed PubMed Central Google Scholar
Boehm KM, El Nahhas OSM, Marra A, Waters M, Jee J, Braunstein L, et al. Multimodal histopathologic models stratify hormone receptor-positive early breast cancer. NAT COMMUN. 2025;16(1):2106. https://doi.org/10.1038/s41467-025-57283-x.
Article CAS PubMed PubMed Central Google Scholar
Chen T, Wen J, Shen X, Shen J, Deng J, Zhao M, et al. Whole slide image based deep learning refines prognosis and therapeutic response evaluation in lung adenocarcinoma. NPJ DIGIT MED. 2025;8(1):69. https://doi.org/10.1038/s41746-025-01470-z.
Article PubMed PubMed Central Google Scholar
Jasti J, Zhong H, Panwar V, Jarmale V, Miyata J, Carrillo D, et al. Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial. NAT COMMUN. 2025;16(1):2610. https://doi.org/10.1038/s41467-025-57717-6.
Article CAS PubMed PubMed Central Google Scholar
Zheng J, Wang T, Wang H, Yan B, Lai J, Qiu K, et al. Use of a pathomics nomogram to predict postoperative liver metastasis in patients with stage III colorectal Cancer. ANN SURG ONCOL. 2025;32(2):771–82. https://doi.org/10.1245/s10434-024-16519-8.
Hosseini MS, Bejnordi BE, Trinh VQ, Chan L, Hasan D, Li X, et al. Computational pathology: A survey review and the way forward. J Pathol Inf. 2024;15:100357. https://doi.org/10.1016/j.jpi.2023.100357.
Komura D, Ochi M, Ishikawa S. Machine learning methods for histopathological image analysis: updates in 2024. COMPUT STRUCT BIOTEC. 2025;27:383–400. https://doi.org/10.1016/j.csbj.2024.12.033.
Saillard C, Schmauch B, Laifa O, Moarii M, Toldo S, Zaslavskiy M, et al. Predicting survival after hepatocellular carcinoma resection using deep learning on histological slides. Hepatology. 2020;72(6):2000–13. https://doi.org/10.1002/hep.31207.
Marra A, Morganti S, Pareja F, Campanella G, Bibeau F, Fuchs T, et al. Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives. ANN ONCOL. 2025;36(7):712–25. https://doi.org/10.1016/j.annonc.2025.03.006.
Article CAS PubMed Google Scholar
Qu W, Tian M, Lu H, Zhou Y, Liu W, Tang Z, et al. Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation. HEPATOL INT. 2023;17(4):927–41. https://doi.org/10.1007/s12072-023-10511-2.
Li Y, Xiong J, Hu Z, Chang Q, Ren N, Zhong F, et al. Denoised recurrence label-based deep learning for prediction of postoperative recurrence risk and Sorafenib response in HCC. BMC MED. 2025;23(1):162. https://doi.org/10.1186/s12916-025-03977-4.
Article CAS PubMed PubMed Central Google Scholar
Pantanowitz L, Pearce T, Abukhiran I, Hanna M, Wheeler S, Soong TR, et al. Nongenerative artificial intelligence in medicine: advancements and applications in supervised and unsupervised machine learning. Mod PATHOL. 2025;38(3):100680. https://doi.org/10.1016/j.modpat.2024.100680.
Liao H, Long Y, Han R, Wang W, Xu L, Liao M, et al. Deep learning-based classification and mutation prediction from histopathological images of hepatocellular carcinoma. CLIN TRANSL MED. 2020;10(2):e102. https://doi.org/10.1002/ctm2.102.
Article PubMed PubMed Central Google Scholar
Sun C, Xu A, Liu D, Xiong Z, Zhao F, Ding W. Deep Learning-Based classification of liver Cancer histopathology images using only global labels. IEEE J BIOMED HEALTH. 2020;24(6):1643–51. https://doi.org/10.1109/JBHI.2019.2949837.
Troiano M, Grignaffini F, De Stefanis C, D’Oria V, Bianchi M, Mangini F, et a
Comments (0)